Colorectal cancer Trials in Lynchburg, United States
Conditions / Colorectal cancer / Lynchburg, United States
Clinical trials for Colorectal cancer investigate a range of treatment strategies and patient populations.
14 total trials for this combination
Showing top 10 of 14 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT04144738 | Clinical Validation of An Optimized Multi-Target Stool DNA (Mt-sDNA 2.0) Test, for Colorectal Cancer Screening BLUE-C | COMPLETED | — |
| NCT02503696 | Sample Collection Study to Evaluate DNA Markers in Subjects With Inflammatory Bowel Disease (IBD) | COMPLETED | — |
| NCT01819766 | Detection of Advanced Colorectal Neoplasia by Stool DNA in Inflammatory Bowel Disease | COMPLETED | — |
| NCT01397747 | Multi-Target Colorectal Cancer Screening Test for the Detection of Colorectal Advanced Adenomatous Polyps and Cancer | COMPLETED | — |
| NCT01515787 | PROSPECT: Chemotherapy Alone or Chemotherapy Plus Radiation Therapy in Treating Patients With Locally Advanced Rectal Cancer Undergoing Surgery | UNKNOWN | PHASE2/PHASE3 |
| NCT00911170 | PAVES: Pegfilgrastim Anti-vascular Endothelial Growth Factor (VEGF) Evaluation Study | COMPLETED | PHASE3 |
| NCT04136002 | Evaluation of the ctDNA LUNAR Test in an Average Patient Screening Episode | COMPLETED | — |
| NCT00265850 | Cetuximab and/or Bevacizumab Combined With Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer | COMPLETED | PHASE3 |
| NCT04369053 | Prevention of Colorectal Cancer Through Multiomics Blood Testing | COMPLETED | — |
| NCT04144751 | Blood Collection Sub-Study of Exact Sciences Protocol 2019-01: Clinical Validation of an Optimized Multi-Target Stool DNA (Mt-sDNA 2.0) Test, For Colorectal Cancer Screening BLUE-C | COMPLETED | — |